The Conolidine Diaries
Our profiling and comparison from the steps of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.two channel blocker, ω-conotoxin CVIE.Most recently, it has been determined that conolidine and the above mentioned derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in very similar r